Pearl Therapeutics’ Bronchodilator Combination Therapeutic For COPD To Be Presented At The American Thoracic Society …
Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, announced four upcoming poster presentations at the Annual Meeting of the American Thoracic Society (ATS) to be held at the Ernest N. Morial Convention Center in New Orleans from May 14-19, 2010. Results from Pearl’s …
Read more on Medical News Today